AstraZeneca to invest $2 billion in Summit Therapeutics for 12% stake
Deal covers newly issued preferred shares convertible into common stock. Closing is expected within one week.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.